Endocrinology, Vol 133, 1532-1538, Copyright © 1993 by Endocrine Society

ARTICLES

Ovarian thecal/interstitial androgen synthesis is enhanced by a follicle-stimulating hormone-stimulated paracrine mechanism

CD Smyth, F Miro, PF Whitelaw, CM Howles and SG Hillier
Department of Obstetrics and Gynecology, University of Edinburgh Center for Reproductive Biology, Scotland, United Kingdom.

To obtain direct evidence for FSH-stimulated paracrine signaling in the ovary, 21-day-old intact or hypophysectomized female Wistar rats received four sc injections of recombinant human FSH (rhFSH; total dose, 16-72 IU) at 12-h intervals. Ovaries were removed 48 h after the first injection to extract total RNA for Northern analysis of 17- hydroxylase/C17-20-lyase (cytochrome P450c17 alpha) mRNA or to isolate thecal/interstitial cells for assessment of basal and hLH-responsive androgen synthesis in vitro. In situ hybridization with a 35S-labeled cytochrome P450c17 alpha cRNA probe confirmed that expression of the cytochrome P450c17 alpha gene was specific to thecal/interstitial cells. The approximately 2.0-kilobase P450c17 alpha mRNA signal in ovarian total RNA from intact animals was increased approximately 5- fold by treatment with rhFSH (total dose, 72 IU) or PMSG (15 IU). This effect was shown to be dose dependent, with a approximately 2-fold increase in response to 16 IU (total dose) rhFSH. P450c17 alpha mRNA levels in isolated granulosa and thecal/interstitial cell total RNA from intact animals were compared to establish which was the principal cellular site of P450c17 alpha mRNA expression. The P450c17 alpha mRNA signal was undetectable in control granulosa cells and only barely discernible after treatment with 72 IU (total dose) rhFSH. In contrast, P450c17 alpha mRNA was abundant in control thecal/interstitial mRNA, and its level was increased 4- to 6-fold by treatment with rhFSH. Treatment of hypophysectomized animals with rhFSH did not consistently alter ovarian P450c17 alpha mRNA levels. During culture for 48 h in serum-free medium, basal androgen (androstenedione plus androsterone) production by thecal/interstitial cells from intact animals was unaffected by treatment with rhFSH in vivo, but hLH-stimulated androgen production by these cells was enhanced approximately 2-fold. Neither basal nor hLH-responsive androgen production by thecal/interstitial cells from hypophysectomized animals was altered by previous treatment with rhFSH in vivo. Treatment of thecal/interstitial cell cultures from both intact and hypophysectomized animals with inhibin (0.1-30 ng/ml), a putative granulosa-derived paracrine factor, did not measurably affect basal androgen synthesis, but potently enhanced LH-responsive androgen synthesis in vitro. Similarly, treatment of thecal/interstitial cell cultures with conditioned medium from FSH- treated granulosa cell cultures significantly enhanced LH-responsive, but not basal, androgen production. We conclude that treatment of pituitary-intact rats with "pure" FSH modulates thecal/interstitial cell androgen synthesis. Granulosa cells, but not thecal cells, possess FSH receptors, and thecal/interstitial cells are the principal ovarian sites of P450c17 alpha expression.(ABSTRACT TRUNCATED AT 400 WORDS)

This article has been cited by other articles:

				D. S. Wachs, M. S. Coffler, P. J. Malcom, S. Shimasaki, and R. J. Chang Increased Androgen Response to Follicle-Stimulating Hormone Administration in Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1827 - 1833. [Abstract] [Full Text] [PDF]

				C. I. Durnerin, K. Erb, R. Fleming, H. Hillier, S.G. Hillier, C.M. Howles, J.-N. Hugues, A. Lass, H. Lyall, P. Rasmussen, et al. Effects of recombinant LH treatment on folliculogenesis and responsiveness to FSH stimulation Hum. Reprod., February 1, 2008; 23(2): 421 - 426. [Abstract] [Full Text] [PDF]

				A. Honda, M. Hirose, K. Hara, S. Matoba, K. Inoue, H. Miki, H. Hiura, M. Kanatsu-Shinohara, Y. Kanai, T. Kono, et al. Isolation, characterization, and in vitro and in vivo differentiation of putative thecal stem cells PNAS, July 24, 2007; 104(30): 12389 - 12394. [Abstract] [Full Text] [PDF]

				J. Smitz, A.N. Andersen, P. Devroey, J.-C. Arce, and for the MERIT Group Endocrine profile in serum and follicular fluid differs after ovarian stimulation with HP-hMG or recombinant FSH in IVF patients Hum. Reprod., March 1, 2007; 22(3): 676 - 687. [Abstract] [Full Text] [PDF]

				D. A. Dumesic, R. D. Schramm, I. M. Bird, E. Peterson, A. M. Paprocki, R. Zhou, and D. H. Abbott Reduced Intrafollicular Androstenedione and Estradiol Levels in Early-Treated Prenatally Androgenized Female Rhesus Monkeys Receiving Follicle-Stimulating Hormone Therapy for In Vitro Fertilization Biol Reprod, October 1, 2003; 69(4): 1213 - 1219. [Abstract] [Full Text] [PDF]

				M. Paciga, A. J. Watson, G. E. DiMattia, and G. F. Wagner Ovarian Stanniocalcin Is Structurally Unique in Mammals and Its Production and Release Are Regulated through the Luteinizing Hormone Receptor Endocrinology, October 1, 2002; 143(10): 3925 - 3934. [Abstract] [Full Text] [PDF]

				R. B. Barnes, R. L. Rosenfield, A. Namnoum, and L. C. Layman Effect of Follicle-Stimulating Hormone on Ovarian Androgen Production in a Woman with Isolated Follicle-Stimulating Hormone Deficiency N. Engl. J. Med., October 19, 2000; 343(16): 1197 - 1198. [Full Text]

				E. V. Solovyeva, M. Hayashi, K. Margi, C. Barkats, C. Klein, A. Amsterdam, A. J.W. Hsueh, and A. Tsafriri Growth Differentiation Factor-9 Stimulates Rat Theca-Interstitial Cell Androgen Biosynthesis Biol Reprod, October 1, 2000; 63(4): 1214 - 1218. [Abstract] [Full Text]

				O.H. Develioglu, B. Cox, J.P. Toner, S. Oehninger, and S.J. Muasher The value of basal serum follicle stimulating hormone, luteinizing hormone and oestradiol concentrations following pituitary down-regulation in predicting ovarian response to stimulation with highly purified follicle stimulating hormone* Hum. Reprod., May 1, 1999; 14(5): 1168 - 1174. [Abstract] [Full Text] [PDF]

				W. L. Zheng, R. A. Bucco, E. Sierra-Rievera, K. G. Osteen, M. H. Melner, and D. E. Ong Synthesis of Retinoic Acid by Rat Ovarian Cells That Express Cellular Retinoic Acid-Binding Protein-II Biol Reprod, January 1, 1999; 60(1): 110 - 114. [Abstract] [Full Text]

				R. Varghese, C. K. C. Wong, H. Deol, G. F. Wagner, and G. E. DiMattia Comparative Analysis of Mammalian Stanniocalcin Genes Endocrinology, November 1, 1998; 139(11): 4714 - 4725. [Abstract] [Full Text] [PDF]

				L. C. Layman, E.-J. Lee, D. B. Peak, A. B. Namnoum, K. V. Vu, B. L. van Lingen, M. R. Gray, P. G. McDonough, R. H. Reindollar, and J. L. Jameson Delayed Puberty and Hypogonadism Caused by Mutations in the Follicle-Stimulating Hormone {beta}-Subunit Gene N. Engl. J. Med., August 28, 1997; 337(9): 607 - 611. [Full Text] [PDF]